Terms: = Brain cancer AND MN1, Q10571, MGCR1-PEN, MGCR1, MGCR, dJ353E16_2, ENSG00000169184, 4330 AND Treatment
23196 results:
1. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
[TBL] [Abstract] [Full Text] [Related]
2. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
4. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of treatment response after stereotactic radiosurgery of brain metastasis using deep learning and radiomics on longitudinal MRI data.
Cho SJ; Cho W; Choi D; Sim G; Jeong SY; Baik SH; Bae YJ; Choi BS; Kim JH; Yoo S; Han JH; Kim CY; Choo J; Sunwoo L
Sci Rep; 2024 May; 14(1):11085. PubMed ID: 38750084
[TBL] [Abstract] [Full Text] [Related]
6. Zavegepant for Acute treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Suresh V; Bardhan M; Dave T; Shamim MA; Suresh D; Satish P; Dhakal B; Bhonsale A; Roy P; Padhi BK; Monteith T
Clin Neuropharmacol; 2024 May-Jun 01; 47(3):72-81. PubMed ID: 38743600
[TBL] [Abstract] [Full Text] [Related]
7. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
[TBL] [Abstract] [Full Text] [Related]
8. Epidemiology and Management Trends of Neuro-Oncology in Nigeria: A Systematic Review and Pooled Analysis.
Ukachukwu AK; Seas A; Oboh EC; Paradie E; Oyemolade TA; Nwaribe EE; Nischal SA; Hughes JG; Ogundeji OD; Badejo OA; Malomo TA; Okere OE; Abu-Bonsrah N; Still MEH; Waguia-Kouam R; Trillo-Ordonez Y; Asemota I; Oboh EN; Rahman R; Reddy P; Ugorji C; von Isenburg M; Fuller AT; Haglund MM; Adeleye AO
World Neurosurg; 2024 May; 185():e185-e208. PubMed ID: 38741325
[TBL] [Abstract] [Full Text] [Related]
9. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
[TBL] [Abstract] [Full Text] [Related]
10. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract] [Full Text] [Related]
11. Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
Petit T; Hajjaji N; Antoine EC; Benderra MA; Gozy M; Foa C; Mouysset JL; Grenier J; Mousseau M; Mailliez A; Saghatchian M; Lachaier E; Desmoulins I; Hennequin A; Maes P; Loirat D; Ricci F; Diéras V; Berton D; Tiong FL; Teixeira L; Dohollou N; Lévy C; Bachelot T; Pierga JY
Cancer Med; 2024 May; 13(9):e7168. PubMed ID: 38733172
[TBL] [Abstract] [Full Text] [Related]
12. In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM.
Pompili SVB; Fanzini S; Schachner M; Chen S
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732030
[TBL] [Abstract] [Full Text] [Related]
13. MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients.
Affronti ML; Lee J; Molassiotis A; Johnson L; Tinianov S; Clark-Snow R; Scotte F
Support Care Cancer; 2024 May; 32(6):335. PubMed ID: 38727834
[TBL] [Abstract] [Full Text] [Related]
14. A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives.
Montoya M; Gallus M; Phyu S; Haegelin J; de Groot J; Okada H
Cells; 2024 Apr; 13(9):. PubMed ID: 38727262
[TBL] [Abstract] [Full Text] [Related]
15. Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.
Baugh R; Khalique H; Page E; Lei-Rossmann J; Wan PK; Johanssen T; Ebner D; Ansorge O; Seymour LW
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724464
[TBL] [Abstract] [Full Text] [Related]
16. State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.
Schaff LR; Ioannou M; Geurts M; van den Bent MJ; Mellinghoff IK; Schreck KC
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431450. PubMed ID: 38723228
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer.
Li L; Xu C; Wang W; Zhang Q
Clin Respir J; 2024 May; 18(5):e13763. PubMed ID: 38717297
[TBL] [Abstract] [Full Text] [Related]
18. YANK2 activated by Fyn promotes glioma tumorigenesis via the mTOR-independent p70S6K activation pathway.
Shi Y; Cheng Y; Wang W; Tang L; Li W; Zhang L; Yuan Z; Zhu F; Duan Q
Sci Rep; 2024 May; 14(1):10507. PubMed ID: 38714727
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
Richard N; Arab-Hocine N; Vannier M; Leblanc-Boubchir R; Pelaquier A; Boruchowicz A; Musikas M; Amil M; Fumery M; Nahon S; Arotcarena R; Gelsi E; Maurin A; Hébuterne X; Savoye G
Age Ageing; 2024 May; 53(5):. PubMed ID: 38706390
[TBL] [Abstract] [Full Text] [Related]
20. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
[TBL] [Abstract] [Full Text] [Related]
[Next]
